Company / Book Value per Share
Astria Therapeutics, Inc. Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$5.685
FY2024
5-year range
$5.685 / $15.13
FY2020-FY2024
Trend
-29.6%
vs FY2023
Sector context
#103 of 209
Health Care
What the data says
At $5.685, Astria Therapeutics, Inc.'s book value per share ranks #103 of 209 in the Health Care sector. Book Value per Share has fluctuated over the past 10 years, ranging from $1.792 in FY2016 to $15.13 in FY2022.
Based on SEC 10-K filings.
$5.685 in FY2024 with a 5-year CAGR of +9.0%.
Declined from $15.13 to $5.685 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -25.4%
- 5-Year CAGR
- +9.0%
- 10-Year CAGR
- -
Sector benchmark
#103 of 209 in Health CareTop 49% of 209This company $5.685 Sector average $189.406
▼
-97.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.0%, indicating consistent growth.
- In FY2024, book value per share decreased 29.6% year-over-year.
- Ranks #103 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.685 | -29.6% |
| FY2023 | $8.071 | -46.7% |
| FY2022 | $15.13 | +10.4% |
| FY2021 | $13.704 | +3.1% |
| FY2020 | $13.297 | +260.6% |
| FY2019 | $3.688 | -46.7% |
| FY2018 | $6.913 | +27.1% |
| FY2017 | $5.439 | +203.5% |
| FY2016 | $1.792 | -71.5% |
| FY2015 | $6.279 | +103.6% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026